Cargando…
Process Development of Sj-p80: A Low-Cost Transmission-Blocking Veterinary Vaccine for Asiatic Schistosomiasis
Asiatic schistosomiasis caused by Schistosoma japonicum is a neglected tropical disease resulting in significant morbidity to both humans and animals - particularly bovines - in endemic areas. Infection with this parasite leads to less healthy herds, causing problems in communities which rely on bov...
Autores principales: | Molehin, Adebayo J., Gray, Sean A., Turner, Cheri, Davis, Jennifer, Zhang, Weidong, Khatoon, Sabiha, Rattan, Madison, Kernen, Rebecca, Peterson, Christopher, Sennoune, Souad R., Carter, Darrick, Siddiqui, Afzal A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959798/ https://www.ncbi.nlm.nih.gov/pubmed/33732227 http://dx.doi.org/10.3389/fimmu.2020.578715 |
Ejemplares similares
-
Sm-p80-based schistosomiasis vaccine mediated epistatic interactions identified potential immune signatures for vaccine efficacy in mice and baboons
por: Rojo, Juan U., et al.
Publicado: (2017) -
Fifteen Years of Sm-p80-Based Vaccine Trials in Nonhuman Primates: Antibodies From Vaccinated Baboons Confer Protection in vivo and in vitro From Schistosoma mansoni and Identification of Putative Correlative Markers of Protection
por: Zhang, Weidong, et al.
Publicado: (2020) -
Elucidation of Cellular Responses in Non-human Primates With Chronic Schistosomiasis Followed by Praziquantel Treatment
por: Melkus, Michael W., et al.
Publicado: (2020) -
Schistosoma mansoni antigen Sm-p80: prophylactic efficacy using TLR4 agonist vaccine adjuvant glucopyranosyl lipid A-Alum in murine and non-human primate models
por: Zhang, Weidong, et al.
Publicado: (2018) -
Schistosomiasis vaccine development: update on human clinical trials
por: Molehin, Adebayo J.
Publicado: (2020)